Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Ocugenix Logo
Ocugenix Growth Score
26
CB Rank
107828
Heat Score
73
Ocugenix is a therapeutics company that develops treatments for angio-fibrotic diseases of the eye.
Founded
obfuscation
PrivateSeed Pittsburgh, Pennsylvania, United States1-10 ocugenix.com
Biotechnology
Health Care
Medical
Therapeutics
Overview

Ocugenix
Total Funding
obfuscation
Growth Score
26
Heat Score
73

Total Funding
obfuscation
Seed raised
obfuscation
Growth Score26
-2 pts
in past quarter
Heat Score 73
10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Ocugenix

CB Rank
107828
Ocugenix is a therapeutics company that develops treatments for angio-fibrotic diseases of the eye.
Founded
obfuscation
PrivateSeed Pittsburgh, Pennsylvania, United States1-10 ocugenix.com
Biotechnology
Health Care
Medical
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Ocugenix Corp.
Operating Status Active
Company Type For Profit
About the Company
Ocugenix is a therapeutics company focused on the development of cancer immunotherapy drugs intended to treat eye diseases. Its cancer immunotherapy drug is a medicine against drug-resistant bacteria, enabling doctors to perform a cancer-related eye treatment.
Phone Number 412-600-6379
Contact Email info@ocugenix.com
Predictions & Insights

Growth Insight

See this Growth Insight
Ocugenix is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Phase 1 Ocular Indication Programs
Ocugenix is developing treatments for three specific eye conditions, currently in Phase 1 clinical trials.
CXCR3 Signaling Pathway Activation
A therapeutic approach targeting the CXCR3 signaling pathway to promote wound healing and prevent chronic inflammation, fibrosis, and scarring in the eye.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
1
obfuscation
— Seed
obfuscation
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
1
obfuscation
— Seed
obfuscation
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
1
obfuscation
— Seed
obfuscation
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
1
obfuscation
— Seed
obfuscation
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
1
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
1
obfuscation
— Seed
obfuscation
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
1
obfuscation
— Seed
obfuscation
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
1
obfuscation
— Seed
obfuscation
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
1
obfuscation
— Seed
obfuscation
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
1
obfuscation
— Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Innovation Works Logo
Innovation Works
—
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
—
Innovation Works Logo
Innovation Works
—
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
—
Innovation Works Logo
Innovation Works
—
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
—
Innovation Works Logo
Innovation Works
—
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
—
Innovation Works Logo
Innovation Works
—
Seed Round - Ocugenix Logo
Seed Round - Ocugenix
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•May 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 26, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$88.5KThis year, Ocugenix is projected to spend $88.5K on IT, according to Aberdeen.

Active Website Tech Count

2Ocugenix is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl, SSL by Default, and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Ocugenix's headquarters? Ocugenix is located in Pittsburgh, Pennsylvania, United States.Who invested in Ocugenix? Ocugenix is funded by Innovation Works.When was the last funding round for Ocugenix? Ocugenix closed its last funding round on
obfuscation
from a Seed round.Who are Ocugenix's competitors? Alternatives and possible competitors to Ocugenix may include Novartis, Bayer, and  Regeneron.How much funding has Ocugenix raised to date? Ocugenix has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|